National Healthcare Corp

National Healthcare Corp(NHC)の株式分析

$236.010

-6.844 (-2.90%)終値時点

Loading chart…
高値
243.520
始値
242.780
出来高加重平均価格
238.34
出来高
192.91K
時価総額
1.66B
安値
235.490
売買代金
45.98M
EV/EBITDA(TTM)
0.00

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies.

nhccare.com

AI分析 of National Healthcare Corp (NHC)

買い

National Healthcare Corp is a good buy right now due to its strong earnings growth and favorable valuation metrics. The current price is $236.01, with a forward P/E of 9.89, suggesting it is undervalued compared to its earnings potential. Additionally, the company reported Q2 earnings of $40.32 million, a significant increase from last year’s $23.72 million, indicating robust profitability. The main risk is the recent 5-day price change of -2.80%, suggesting some short-term volatility.

バリュエーション指標

National Healthcare Corp(NHC)の現在の予想PERは9.89で、5年平均は1.72です。

予想PER

大幅な割高
5年平均 P/E
1.72
現在のP/E
9.89
割高
5.63
割安
-2.20

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
0.00
現在のEV/EBITDA
0.00
割高
0.00
割安
0.00

予想PSR

大幅な割安
5年平均 P/S
0.00
現在のP/S
0.00
割高
0.00
割安
0.00

Alphio AI による NHC の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%NHC

$104.57

シナリオ価格

基

基本

基本 · 50%NHC

$86.97

シナリオ価格

弱

弱気

弱気 · 25%NHC

$67.53

シナリオ価格

NHC を保有するクジラ

W

Washington H. Soul Pattinson and Company Limited

+ を保有NHCPEN

-13.99%

3か月リターン

イベントタイムライン

2026-08-07 (ET)

07:30:00

Q2 Revenue Reaches $408M vs $375M Last Year

2026-05-08 (ET)

07:11:00

Q1 Revenue Reaches $381.8M

2026-05-07 (ET)

16:50:00

National HealthCare Corporation Increases Quarterly Dividend to $0.67

2026-04-21 (ET)

16:50:00

National HealthCare to Acquire 32 Nursing Facilities for $560M

2025-05-08 (ET)

16:45:53

National Healthcare announces 4.9% increase in quarterly common dividend to 64c

ニュース

NHC のよくある質問 — Alphio AI が回答

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. It operates in the Healthcare sector (SERVICES-SKILLED NURSING CARE FACILITIES industry).

National Healthcare Corp is a good buy right now due to its strong earnings growth and favorable valuation metrics. The current price is $236.01, with a forward P/E of 9.89, suggesting it is undervalued compared to its earnings potential. Additionally, the company reported Q2 earnings of $40.32 million, a significant increase from last year’s $23.72 million, indicating robust profitability. The main risk is the recent 5-day price change of -2.80%, suggesting some short-term volatility.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める